A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
for Sickle Cell Disease
23 locations incl. Phoenix
Sponsor: Novo Nordisk A/S
Sex: All·Age: 2+
Code: NCT06609226·Phase 3·Recruiting·Listed Sep 2024